0      0


The Effect of Treatment with the Complement C5a Receptor Inhibitor Avacopan on Health-Related Quality of Life in ANCA-Associated Vasculitis


‐ Mar 20, 2022 10:00am


Speaker(s):

You must be logged in and own this session in order to post comments.